What is it about?
Tyrosine-protein kinase Yes inhibitors were competitively inferred by in silico drug discovery methodology between various independet research groups
Featured Image
Why is it important?
Competitive trials turned out to be effective to identify new inhibitors in silico
Perspectives
I attended this contest since we would like to prove the efficiency of the methodology developed by co-authors, FAMS and ChoseLD.
Professor Y-h. Taguchi
Chuo Daigaku
Read the Original
This page is a summary of: Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target, Scientific Reports, November 2015, Nature,
DOI: 10.1038/srep17209.
You can read the full text:
Contributors
The following have contributed to this page
